These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28397841)

  • 21. Regional brain mGlu5 receptor occupancy following single oral doses of mavoglurant as measured by [
    Streffer J; Treyer V; Buck A; Ametamey SM; Blagoev M; Maguire RP; Gautier A; Auberson YP; Schmidt ME; Vranesic IT; Gomez-Mancilla B; Gasparini F
    Neuroimage; 2021 Apr; 230():117785. PubMed ID: 33545349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats.
    Gokalp D; Unal G
    Psychopharmacology (Berl); 2024 Jul; 241(7):1399-1415. PubMed ID: 38459971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
    DuBois JM; Rousset OG; Guiot MC; Hall JA; Reader AJ; Soucy JP; Rosa-Neto P; Kobayashi E
    Cereb Cortex; 2016 Oct; 26(11):4170-4179. PubMed ID: 27578494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling.
    Gilbert JR; Yarrington JS; Wills KE; Nugent AC; Zarate CA
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):740-747. PubMed ID: 29668918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [
    DeLorenzo C; Gallezot JD; Gardus J; Yang J; Planeta B; Nabulsi N; Ogden RT; Labaree DC; Huang YH; Mann JJ; Gasparini F; Lin X; Javitch JA; Parsey RV; Carson RE; Esterlis I
    J Cereb Blood Flow Metab; 2017 Aug; 37(8):2716-2727. PubMed ID: 27742888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques.
    Yamanaka H; Yokoyama C; Mizuma H; Kurai S; Finnema SJ; Halldin C; Doi H; Onoe H
    Transl Psychiatry; 2014 Jan; 4(1):e342. PubMed ID: 24399045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
    Kokane SS; Armant RJ; Bolaños-Guzmán CA; Perrotti LI
    Behav Brain Res; 2020 Apr; 384():112548. PubMed ID: 32061748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
    Salvadore G; van der Veen JW; Zhang Y; Marenco S; Machado-Vieira R; Baumann J; Ibrahim LA; Luckenbaugh DA; Shen J; Drevets WC; Zarate CA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1063-72. PubMed ID: 22040773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688.
    DeLorenzo C; Kumar JS; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2011 Nov; 31(11):2169-80. PubMed ID: 21792244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.
    Davis MT; Hillmer A; Holmes SE; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Angarita GA; Carson RE; Krystal JH; Esterlis I
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11490-11495. PubMed ID: 31085640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [
    Fang XT; Eriksson J; Antoni G; Yngve U; Cato L; Lannfelt L; Sehlin D; Syvänen S
    Neuropharmacology; 2017 Feb; 113(Pt A):293-300. PubMed ID: 27743932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized placebo-controlled PET study of ketamine´s effect on serotonin
    Tiger M; Veldman ER; Ekman CJ; Halldin C; Svenningsson P; Lundberg J
    Transl Psychiatry; 2020 Jun; 10(1):159. PubMed ID: 32475989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder.
    Kim JH; Joo YH; Son YD; Kim HK; Kim JH
    Neuropsychiatr Dis Treat; 2022; 18():2041-2053. PubMed ID: 36124236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
    Kosten L; Verhaeghe J; Verkerk R; Thomae D; De Picker L; Wyffels L; Van Eetveldt A; Dedeurwaerdere S; Stroobants S; Staelens S
    Psychiatry Res Neuroimaging; 2016 Feb; 248():1-11. PubMed ID: 26803479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting glutamate signalling in depression: progress and prospects.
    Murrough JW; Abdallah CG; Mathew SJ
    Nat Rev Drug Discov; 2017 Jul; 16(7):472-486. PubMed ID: 28303025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.
    DeLorenzo C; Milak MS; Brennan KG; Kumar JS; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1083-94. PubMed ID: 21279350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.